Why the study?
Current guidelines only support inotrope use in acute decompensated heart failure with organ malperfusion or shock, but inotropic support may be reasonable in other advanced heart failure settings.
This consensus statement provides guidance on the use of inotropic therapy in advanced heart failure, expanding considerations beyond acute decompensation to include palliation, home therapy, and bridge to advanced therapies.
No takes yet. Share an insight, caveat, or question.
Informs inotropic decisions in non-acute advanced HF including palliation and bridging; extends prior guidelines beyond acute decompensation.
Gustafsson et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: